(hyperpipecolic acidaemia) is used as a marker of pyridoxine dependent epilepsy and AASDH deficiency [Stockler et al., 2011] , and is associated with peroxisome biogenesis disorders such as Zellweger syndrome [Wanders et al., 1988; Moser et al., 1989] .
Our interest in l-pipecolic acid is from a previous study in which we tested the ability of proline and proline analogs to protect mammalian cells against oxidative stress. In addition to proline, we found that pipecolate, a six-member proline analog, significantly increased cell survival after exposure to H 2 O 2 stress [Krishnan et al., 2008] . The mechanism by which proline improves cell survival was shown to be mediated by proline dehydrogenase (PRODH) . PRODH is a mitochondrial enzyme that performs the first step of proline degradation by catalyzing the oxidation of proline to Δ 1pyrroline-5-carboxylate (P5C) (Fig. 1B) , which is then converted into glutamate by P5C dehydrogenase. Knockdown of PRODH eliminated the protective effect of proline against H2O2 stress . Additionally, it was shown that proline and PRODH increase activation of Akt signaling during stress suggesting a mechanism for how proline enhances cell survival .
Here we investigate the mechanism of pipecolate protection against H 2 O 2 induced cell death. PIPOX catalyzes the oxidation of l-pipecolate in a reaction analogous to PRODH (Fig.  1A) suggesting that similar to proline, the protective effect of pipecolate may depend on this first oxidative step. The role of PIPOX in pipecolate protection was thus examined and the mechanistic target of rapamycin complex (mTOR) and Akt kinase were explored to test their potential involvement in pipecolate protection. Subcellular localization of PIPOX was also assessed to establish whether PIPOX is expressed in mitochondria. We found that in HEK293 cells a majority of PIPOX localizes to mitochondria and our results suggest that the mechanism by which pipecolate provides cellular stress protection parallels that of proline.
Materials and Methods

Materials
Unless stated otherwise, all chemicals, enzymes, and buffers were purchased from Fisher Scientific and Sigma-Aldrich, Inc. For this study, we used human embryonic kidney 293 (HEK293) cells purchased from ATCC.
Antibodies
Antibodies recognizing VDAC/Porin (#V2139) and b-Actin (#A5441) were from Sigma. The monoclonal antibody against PIPOX (PIPOX F-9, #sc-166749) was from Santa-Cruz and anticatalase antibody (#ab15834) was from Abcam. Antibodies against phospho-Akt T308 (#4056), phospho-Akt S473 (#4058), phospho-JNK (#4668), phospho-FoxO3 (Thr32) (#9464) and total forms of FoxO3 (#2497), Akt (#4685), and JNK (#9252) were from Cell Signaling Technology. Horseradish peroxidase-labeled anti-mouse (#NA931), and anti-rabbit (#RPN4301) secondary antibodies were from GE Healthcare.
Stress Tests and Cell Viability
HEK293 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% FBS and penicillin-streptomycin (100 U/ml). For stress treatments, HEK293 were grown to 80% confluence and then pretreated with and without lpipecolate in serum containing medium for 12 h. After the pretreatment period, cells were exposed to H 2 O 2 (50 and 500 μM) for 3 h in serum free medium with and without l-pipecolate. Reactions catalyzed by pipecolate oxidase and proline dehydrogenase. (A) Pipecolate oxidase (PIPOX) catalyzes the oxidation of l-pipecolate (Pipe) to Δ 1 -piperideine-6-carboxylate (P6C). P6C spontaneously hydrolyzes to form a-aminoadipic semialdehyde (AAS). (B) In an analogous reaction, proline dehydrogenase (PRODH) catalyzes the oxidation of l-proline (Pro) to Δ 1 -pyrroline-5-carboxylate (P5C), which spontaneously hydrolyzes to glutamate γ-semialdehyde (GSA).
The protective effect of pipecolate was initially tested with different pipecolate concentrations (0.05-10 mM) and then 1, 5, and 10 mM l-pipecolate were used in subsequent experiments. After stress treatment, cell viability was quantified using the tetrazolium compound [3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] (MTS) according to the recommendation of the manufacturers (Promega). The CellTiter-Glo Luminescent assay (Promega) was also used as an alternative method according to the recommendation of the manufacturers. Percent cell survival was determined relative to the appropriate controls. Stress tests with proline were performed similarly to pipecolate but using 5 mM l-proline. Stress tests were also performed in the presence of different inhibitor compounds. To inhibit the pentose phosphate pathway, HEK293 cells were incubated with 6-aminonicotinamide (6-AN) (50 μM) or dehydroepiandrosterone (DHEA) (50 μM) for 24 h before adding pipecolate (10 mM) to the cell culture. After 12 h incubation with pipecolate, cells were then treated with H 2 O 2 as described above. Inhibition of the mechanistic target of rapamycin (mTOR) pathway was achieved by incubating HEK293 cells with rapamycin (Calbiochem) at 10 and 100nM concentrations for 2 h prior to H 2 O 2 stress. Inhibition of both mTORC1 and mTORC2 was achieved by incubating HEK293 cells with 10 nM of KU-0063794 for 2 h prior to H 2 O 2 stress. To inhibit Akt activity, HEK293 were treated with 10 μM Akt Inhibitor VIII (Akti-Calbiochem), which selectively inhibits Akt1/Akt2 activity, for 30 min prior to H 2 O 2 stress. Stock solutions of the inhibitor compounds DHEA, 6-AN, rapamycin, and Akti were prepared in dimethyl sulfoxide (DMSO).
G6pdh Assay and NADPH Measurements
Glucose-6-phosphate dehydrogenase (G6PDH) activity was measured according to the recommendation of the manufacturer (BioVision). One unit of enzyme is defined as 1 μmol of product formed per min at 37°C. Total protein concentration in the cell lysates was determined using the bicinchoninic acid (BCA) protein assay (Pierce) using bovine serum albumin as a standard. Cellular NADPH/NADP + (MilliporeSigma) levels were estimated as previously described according to the manufacturer's recommendation .
Western Blot Analysis
Cells grown in 10-cm diameter dishes were rinsed once with ice cold PBS and cell lysates were prepared using M-PER according to the recommendation of the manufacturers along with the addition of mammalian protease inhibitor cocktail (Sigma) and HALT-phosphatase inhibitor (Pierce). Lysates containing 50-100 μg of protein were resolved by SDS-PAGE. Proteins were transferred to a PVDF membrane and visualized by immunoblotting.
Mitochondrial Isolation
Cells were released with trypsin and washed twice via centrifugation with ice cold PBS. Cell pellets were then resuspended in Tris buffer (5 mM, pH 7.4) containing 0.25 M sucrose, 1 mM EDTA, and mammalian protease inhibitor cocktail (Sigma). The resuspended cells were next hand homogenized using a dounce homogenizer for 1 min on ice. Mitochondria and cytosolic fractions were isolated by differential centrifugation as described [Natarajan et al., 2006a] . Briefly, cell homogenates were first centrifuged at 600g for 10 min to remove cell debris. Mitochondria were then pelleted at 17,000g for 15 min (4°C) and washed twice with mitochondrial suspension buffer (5 mM Tris, pH 7.4, 0.25 M sucrose). The post-mitochondrial supernatant was then centrifuged at 32,000g for 20 min to isolate the peroxisome fraction [Natarajan et al., 2006a] . The peroxisomal fraction was resuspended in the mitochondrial suspension buffer and then centrifuged at 17,000g for 15 min to remove mitochondria. The supernatant was then centrifuged again at 32,000g for 20 min to collect pure peroxisomes [Natarajan et al., 2006a,b] . The postperoxisomal supernatant was centrifuged at 105,000g for 1 h to isolate the cytosolic fraction [Natarajan et al., 2006a] . Density-purified mitochondria were isolated on a discontinuous Histodenz [5-(N-2,3-Dihydroxy propylacetamido)-2,4,6-triiodo-N,N′-bis(2,3-dihydroxypropyl) isophthalamide] gradient as described [Boldogh and Pon, 2007; Atkinson et al., 2011] . Briefly, the mitochondria-enriched fraction obtained from differential centrifugation was layered onto a discontinuous Histodenz gradient consisting of 14% and 22% layers dissolved in sorbitol buffer. Histodenz gradients were centrifuged at 303,000g for 1 h [Atkinson et al., 2011] . Mitochondrial fractions were then resuspended in mitochondrial suspension buffer and used for Western blot analysis. Total protein concentrations were quantified using the Bradford method (Bio-Rad).
siRNA Transfection
Cells were transfected with On-Target Plus Smart Pool siRNA of PIPOX and On-Target Plus Non-targeting Pool, referred to as control siRNA (Dharmacon RNA Technologies). siRNA transfection was performed for 48 h before doing the stress test or whole cell extract collection. Knockdown was confirmed by immunoblotting. Following transfection, stress tests were performed as described above.
Statistical Analysis
Data are expressed as mean ± standard deviation (SD). Statistical analysis was performed using student's t-test. A P-value of < 0.05 was considered to be statistically significant.
Results
Pipecolate Protects HEK293 Cells
Pipecolate was previously shown to protect HEK293 cells against H 2 O 2 -induced cell death [Krishnan et al., 2008] . Here we pretreated HEK293 cells with different concentrations of pipecolate (0.05-10 mM) for 12 h prior to H 2 O 2 stress treatment (0.5 mM, 3 h). Pipecolate protected HEK293 cells against oxidative stress with significant protection observed at ≥0.75 mM pipecolate relative to control cells without pipecolate supplementation ( Fig.  2A and B) [Krishnan et al., 2008] . The protective effect of pipecolate was also investigated using luminescence quantification of ATP generation. In these assays, pipecolate increased cell survival in HEK293 cells (Fig. 2C ) from 40% to 74%.
Pipecolate protection was also examined at a more pathophysiology-relevant level of oxidative stress by using a lower concentration of H 2 O 2 . At 50 μM H 2 O 2 (3 h), percent cell survival was significantly higher in HEK293 cells treated with pipecolate relative to control cells without pipecolate ( Fig. 2D ). Thus, pipecolate was able to protect cells against a H 2 O 2 concentration that more closely mimics pathophysiological stress.
PIPIX Knockdown by siRNA
We next examined the effect of reducing endogenous PIPOX expression by transfecting HEK293 cells with PIPOX siRNA (siPI-POX). Knockdown of PIPOX expression was confirmed by Western blot analysis of whole cell lysates. PIPOX expression was observed to be significantly lower in HEK293 cells after 48 h of siPIPOX treatment relative to cells treated with control siRNA (Fig. 3A) . In siPIPOX-transfected cells, pipecolate protection against H 2 O 2 -induced cell death was eliminated whereas in control siRNA treated cells pipecolate protection was still observed ( Fig. 3B ). Pipecolate (1-5 mM) was also unprotective in siPIPOX-transfected cells exposed to pathophysiological levels of H 2 O 2 (50 μM) ( Fig. 3C ). Next, we tested whether proline supplementation could protect against H 2 O 2 stress in cells treated with PIPOX siRNA. Proline significantly increased survival of HEK293 cells treated with PIPOX siRNA (Fig. 3D) . These results show that although PIPOX can utilize proline as an alternative substrate, PIPOX is not essential for proline protection. Thus, it appears PIPOX is necessary for pipecolate protection.
PIPOX Subcellular Localization
Because PIPOX was observed to be essential for pipecolate protection, we sought to establish the subcellular localization of PIPOX in HEK293 cells. Human PIPOX terminates at the C-terminus with an Ala-His-Leu tripeptide peroxisome targeting signal [IJlst et al., 2000] , however, PIPOX has been shown previously to localize to the peroxisomes and the mitochondria depending on the species [IJlst et al., 2000] . Western analysis of PIPOX expression in the different subcellular compartments was performed using highly purified mitochondria, peroxisomes, and cytosolic fractions from HEK293 cells. Figure 4 shows that PIPOX was detected predominantly in isolated mitochondria. To check whether the purified mitochondria were contaminated with peroxisomes, we tested for the presence of catalase. High expression levels of catalase were observed in the peroxisomal fraction whereas catalase was not detected in the mitochondria indicating that the purified mitochondria were not contaminated with peroxisomes ( Fig. 4) .
NADPH/NADP + and Pentose Phosphate Pathway
The effect of pipecolate on the NADPH/NADP + ratio was measured in cells before and after H 2 O 2 stress. The cellular NADPH/ NADP + ratio in HEK293 cells decreased in control cells after 3 h of 500 μM H 2 O 2 stress (Fig. 5A ). In cells treated with pipecolate, Fig. 2 . Oxidative stress protection of HEK293 cells by pipecolate. (A) HEK293 cells were treated without pipecolate (Con) and with different concentrations of pipecolate (Pipe) for 12 h (0.05-1 mM). Control and pipecolate treated cells were then incubated in serum free medium with and without 0.5 mM H 2 O 2 for 3 h. Percent cell survival was estimated using the MTS cell viability assay. (B) HEK 293 cells were treated with or without pipecolate (0.75-10 mM) for 12 h. Control and pipecolate treated cells were then incubated in serum free medium with and without 500 μM H 2 O 2 for 3 h. Percent cell survival was estimated using the MTS cell viability assay. (C) HEK293 cells treated with and without pipecolate (10 mM) for 12 h. Control and pipecolate treated cells were then incubated in serum free medium with and without 500 μM H 2 O 2 for 3 h. Percent cell survival was determined using the Cell Titer-Glo Luminescent assay. (D) HEK293 cells were treated as above. Control and pipecolate (10 mM) treated cells were then incubated in serum free medium with and without 50 μM H 2 O 2 for 3 h. Percent cell survival was determined using the Cell Titer-Glo Luminescent assay. Each value represents mean ± SD from five different experiments (n = 5) (* P <0.05). however, the NADPH/NADP + ratio increased during H 2 O 2 stress resulting in a approximately fivefold higher ratio than in control cells (Fig. 5A ). Next, we tested whether increased NADPH/NADP + ratio with pipecolate treatment is via activation of the pentose phosphate pathway. Cells were treated with 6-aminonicotinamide (6-AN) and dehydroepiandrosterone (DHEA), which inhibit glucose 6-phosphate dehydrogenase (G6PDH) of the pentose phosphate pathway. Treatment of cells with 6AN and DHEA showed a significant decrease in G6PDH activity (Fig. 5B) while the pipecolate-induced increase in the NADPH/NADP + ratio was abolished in cells treated with the inhibitors (Fig. 5A) . Further, we also tested the effect of pipecolate protection during inhibition of pentose phosphate pathway. Interestingly, pipecolate protection of HEK293 cells was still observed in the presence of the 6-AN and DHEA indicating that the pentose phosphate pathway is not critical in these H 2 O 2 stress experiments ( Fig. 5C and D) .
Inhibition of mTORC
The mechanistic target of rapamycin complex 1 (mTORC1) is known to be activated by amino acids [Lynch, 2001; Zoncu et al., 2011] and we recently discovered a role for mTORC in proline protection . To test whether mTORC1 and mTORC2 are also involved in pipecolate protection, HEK293 cells were incubated with 10nM rapamycin, a concentration previously shown to inhibit mTORC1 in cells [Lasithiotakis et al., 2008] . Treatment of cells with rapamycin did not attenuate pipecolate protection against H 2 O 2 stress in HEK293 cells (Fig. 6A ) suggesting that mTORC1 is not involved. Treating cells with a higher concentration of rapamycin (100 nM), which inhibits mTORC1 and the Rictor-complex of mTOR (mTORC2) [Sarbassov et al., 2006] , abrogated pipecolate protection (Fig. 6A) implying that mTORC2 may be involved. This was further tested by treating HEK293 cells with 10nM of KU-0063794, which also inhibits mTORC1 and mTORC2. Similar to using a high concentration of rapamycin, treatment of cells with KU-0063794 abolished pipecolate protection against H 2 O 2 stress, suggesting a role for mTORC2 in pipecolate protection (Fig. 6B ).
Role of Akt and FoxO3 during H 2 O 2 Stress
Akt/PKB (Protein kinase B) can significantly impact cell survival and proliferation and, is a downstream target of mTORC2 [Berndt et al., 2010; Altomare and Khaled, 2012] . Cells were treated with the Akt inhibitor, Akti, to test the involvement of Akt in pipecolate protection [Calleja et al., 2009] . At different concentrations of pipecolate (1 and 10 mM), Akti was observed to block pipecolate protection of HEK293 cells against H 2 O 2 stress (Fig. 7A ). Akti inhibition of Akt was confirmed by loss of phosphorylation at Akt residues T308 and S473 as shown in Figure 7B . Exposure of control cells to H 2 O 2 increases phospho-Akt slightly at T308 and more significantly at S473 (Fig. 7B, -Akti) . In the absence of H 2 O 2 , pipecolate does not increase the levels of phospho-Akt at T308 and S473 relative to control cells (Fig. 7B, -Akti) . However, in the presence of H 2 O 2 , pipecolate appears to significantly increase the levels of phospho-Akt at S473 ( Fig. 7B-D, -Akti) . Treatment of cells with Akti abolished phosphorylation of Akt under all conditions consistent with inhibition of the Akt signaling pathway ( Fig. 7B-D, +Akti) . In these experiments, no changes in the levels of total-Akt and the actin control were observed (Fig. 7B) . The effects of Akti on other stress signaling pathways such as c-Jun N-terminal Kinase (JNK) were also examined. Akti did not perturb the phosphorylation status of JNK (Fig. 7E) .
Activation of Akt can lead to phosphorylation of several transcriptions factors including the forkhead transcription factor O3 (FoxO3). To test the downstream effects of Akt in pipecolate protection, phosphorylation of FoxO3 (Thr32) was examined after 0.5 and 3 h of H 2 O 2 stress in cells with or without pipecolate. In control cells, a slight increase in phospho-FoxO3 levels was observed with 0.5 h of H 2 O 2 treatment (Fig. 8A and B) . A much more dramatic increase in phospho-FoxO3, however, was observed with H 2 O 2 (0.5 h) in the presence of pipecolate ( Fig. 8A and B ). Addition of Akti (+Akti) eliminated phosphorylation of FoxO3 indicating involvement of the Akt pathway ( Fig.  8A and B) . At 3 h of H 2 O 2 treatment, phospho-FoxO3 levels remained slightly higher in pipecolate cells relative to control cells (Fig. 8C ). These results suggest increased phosphorylation of FoxO3 is part of the mechanism by which pipecolate protects cells against oxidative stress.
Discussion
Here we show that PIPOX is required for the observed effects of pipecolate, a finding which is analogous to the role of PRODH in proline protection . The specificity of proline and pipecolate protection is governed by PRODH and PIPOX, respectively. Although PIPOX can use proline as a substrate, knockdown of PIPOX does not affect proline protection consistent with PRODH being the key proline catabolic enzyme. Conversely, pipecolate is not expected to be a substrate for PRODH [Zhu et al., 2002] . The mutual protective effects of proline and pipecolate, both of which are transported into mammalian cells via the sodium dependent IMINO transporter and the system IMINO transporter 1 [Kowalczuk et al., 2005; Takanaga et al., 2005] , are likely due to the analogous flavin-dependent catalyzed reactions of PRODH and PIPOX in mitochondria. The oxidation of these related amino acids involves reduction of a flavin cofactor and subsequent electron transfer from the reduced flavin to an electron acceptor. PRODH is a mitochondrial enzyme that couples the oxidation of proline to reduction of the ubiquinone pool in the mitochondrial membrane (Fig. 1) [Wanduragala et al., 2010; Liu et al., 2012] . PRODH activity has been reported to generate reactive oxygen species (ROS) leading to either cell survival or cell death [Liu et al., 2012; Zarse et al., 2012; Zhang et al., 2015] . Here, we show that PIPOX is also predominantly localized in the mitochondria. Whether PIPOX transfers electrons directly to the mitochondrial electron transport chain is not clear but PIPOX has been shown to generate H 2 O 2 during catalytic turnover [Wanders et al., 1989; . Energy metabolism in the mitochondria is a potent source of ROS, which has been shown to have a plethora of effects on cell proliferation, death, and or with 10 μM Akti (+Akti) and treated with and without 500 μM H2O2 stress (3 h) in the absence (Con) and presence of 1 or 10 mM pipecolate (Pipe). Cells treated with DMSO were used as controls. Percent cell survival was estimated using the MTS cell viability assay. Each value represents mean ± SD of separate experiments (n = 5) (* P <0.05). (B) Western analysis of P-Akt (T308 and S473), T-Akt and Actin in HEK293 cells treated with and without pipecolate (1 mM) for 12 h and then incubated with and without 0.5 mM H 2 O 2 for 0.5 h in serum free medium. Western analysis of P-Akt and T-Akt were also determined in cells with similar treatment conditions but in the presence of 10 μM Akt inhibitor (+Akti). Quantified levels of (C) P-Akt (T308) and (D) PAkt (S473) relative to total Akt (P-Akt/Akt). (E) Western analysis of P-JNK, and T-JNK in HEK293 cells treated with and without pipecolate (1 mM) for 12 h and then incubated with and without 0.5 mM H 2 O 2 for 0.5 h in serum free medium. Western analysis of P-JNK and T-JNK were also determined with similar treatment conditions but in the presence of 10 μM Akt inhibitor (+Akti). Blots shown are representative results from three independent experiments. Each value represents the mean ± SD of separate experiments (n = 3) (* P <0.05).
other growth processes Figueira et al., 2013] . We found that pipecolate shifts the redox status of the NADPH/NADP + and helps maintain cellular NADPH/NADP + ratios during stress consistent with PIPOX having a role in redox homeostasis. However, the increased NADPH/NADP + ratio and pentose phosphate pathway were found not be critical for pipecolate protection against H 2 O 2 stress. Further studies are underway to elucidate the mechanism by which pipecolate influences the redox environment during oxidative stress.
Finding that PIPOX was mainly localized in mitochondria of HEK293 cells was unexpected. Previous studies of PIPOX in rat and human liver detected PIPOX activity in both mitochondria and peroxisomes [Wanders et al., 1989; Rao et al., 1993] . The subcellular localization of PIPOX has been shown to be speciesdependent with localization in the peroxisomes suggested to predominate in humans Rhead, 1989, 1991] . In human fibroblasts overexpression of PIPOX resulted in localization of PIPOX in the peroxisomes as detected by immunofluorescence staining [IJlst et al., 2000] . Currently known peroxisomal targeting signals (PTS) are the C-terminal PTS-1 and the N-terminal PTS-2 [Gould and Collins, 2002; Wolf et al., 2010] . PIPOX has a PTS-1 sequence of Ala-His-Leu and does not have a mitochondrial target sequence [IJlst et al., 2000] . Bioinformatics analysis of PIPOX using MitoProt [Claros and Vincens, 1996] , a program that does not rely on identifying a targeting peptide but instead evaluates up to 47 parameters, gives a low probability (MitoProt score of 15%) for PIPOX import into mitochondria despite PIPOX not having a mitochondrial targeting sequence. Another bioinformatics tool, WoLF PSORT [Horton et al., 2007] , predicts that PIPOX is favored to be localized in the mitochondria rather than in the peroxisomes. It is established that peroxisomal targeting sequences do not necessarily limit protein localization to the peroxisomes [Wolf et al., 2010] . In addition, it is becoming more recognized that proteins can be located in more than one compartment [O'Byrne et al., 2003; Hogenboom et al., 2004; Taylor et al., 2004; Yogev and Pines, 2011; Islinger et al., 2012] . Dual localization of proteins can occur by various mechanisms involving two target signals in a single polypeptide and target signals that are inaccessible or ambiguous [O'Byrne et al., 2003; Hogenboom et al., 2004; Taylor et al., 2004; Yogev and Pines, 2011; Islinger et al., 2012] .
Mitochondrial localization of PIPOX in HEK293 cells is consistent with its role in the lysine catabolic pathway, which involves mitochondrial enzymes such as AASDH (also known as AL-DH7A1) [Brocker et al., 2010; Struys and Jakobs, 2010; Stockler et al., 2011; Luo and Tanner, 2015] . Recently, PIPOX was suggested to function as a metabolic repair enzyme by minimizing pipecolate accumulation and increasing the overall conversion of lysine to glutaryl-CoA [Struys and Jakobs, 2010; Van Schaftingen et al., 2013] . Pyrroline-5-carboxylate reductase (P5CR) has been proposed to catalyze the NADPH-dependent reduction of P6C to pipecolate as a side reaction thereby diminishing lysine catabolic efficiency [Struys and Jakobs, 2010; Van Schaftingen et al., 2013] . The preferred substrate for P5CR is Δ 1 -pyrroline-5-carboxylate, but P5CR from Escherichia coli has been shown to convert P6C to pipecolate [Fujii et al., 2002] . Humans have three isoforms of P5CR known as PYCR1, PYCR2, and PYCRL [Reversade et al., 2009; De Ingeniis et al., 2012] . PYCR1 and PYCR2 were recently shown to localize in the mitochondria [Reversade et al., 2009; De Ingeniis et al., 2012] . Finding that PIPOX is also localized in the mitochondria further supports a repair role for PIPOX, which merits future investigation.
The results here with pipecolate and previously with proline , indicate that the protective effects of these amino acids involve the Akt and its downstream mediators. In the previous study with proline, PRODH was shown to increase Akt phosphorylation (Ser473) and phosphorylation of the Akt downstream target, FoxO3 . Phosphorylation of FoxO3 by Akt prevents activation of pro-apoptotic genes thus promoting cell survival [Guo et al., 2011] . In this study, inhibition of Akt abolished phosphorylation of FoxO3 and the protective effect of pipecolate. Thus, the protective mechanism of pipecolate appears to be mediated by Akt and FoxO3. As previously observed with proline, dual inhibition of mTORC complexes, blocks pipecolate protection against oxidative stress. These observations indicate that mTORC2 may be involved in the mechanism of cell protection. mTORC2 has been shown to activate Akt via phosphorylation of Ser473 [Guo et al., 2011; Murata et al., 2011] . How pipecolate and proline influence mTORC2 and Akt signaling is not clear but amino acids have been shown to induce mTORC1 and mTORC2 in mammalian cells [Tato et al., 2011] . In addition, evidence has been reported for mTORC2 being activated by mitochondrial ROS suggesting that the intracellular redox environment modulates mTORC2 [Kumari Kanchan et al., 2012] . Whether ROS is a key mediator by which proline and pipecolate metabolism meditate mTORC2 and Akt pathway activity remains to be determined.
In summary, we show that pipecolate metabolism leads to protection against H 2 O 2 stress in mammalian cells. Our findings expand the potential role of pipecolate metabolism in mediating cell signaling. Previous studies reporting that pipecolate impacts oxidative stress were focused on exploring the role of pipecolate in neurological function. Incubation of rat cerebral cortex supernatants with pipecolate for 1 h was shown to decrease the activity of antioxidant enzymes, an effect that could be blocked by lipoic acid [Dalazen et al., 2014] . Pipecolate was also shown to stimulate apoptotic cell death in neurons [Matsumoto et al., 2003] . Treatment of mouse neuroblastoma cells with d-or lpipecolate over 72 h decreased cell viability with a racemic mixture of dl-pipecolate having the most toxic effect [Matsumoto et al., 2003] . Because d-pipecolate decreased cell viability, the mechanism appears to be independent of pipecolate oxidase activity, which is specific for l-pipecolate [Matsumoto et al., 2003] .
Different roles for d-and l-pipecolate have also been found in other biological contexts such as l-pipecolate acting as an antihypertensive by competitively inhibiting the angiotensin I-converting enzyme, whereas, the d-enantiomer does not have an antihypertensive function [Vranova et al., 2013] . Future studies will investigate the protective role of pipecolate metabolism and downstream pathways involving mTORC2, Akt and FoxO3 using other cell types to broaden our understanding of how pipecolate impacts the cellular redox environment.
